You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

App icon
FreshPublishers
Open in the app
OPEN

MedMen launches $100 million investment fund

MedMen, the only full-service management company serving North America’s legal cannabis industry, has launched the MedMen Opportunity Fund, L.P. (the “Fund”), the first private equity vehicle of its kind. It combines a key understanding of the fragmented regulatory environment and an institutional operating management platform unparalleled in the industry.

The Fund will pursue strategic investments in supply-constrained, high barrier to entry markets and be diversified on both an asset and geographic basis. It will also own a portion of MedMen’s management company, which will serve as the Fund's captive operating partner, providing unrivaled resources and operational oversight for the Fund’s assets.

"We pride ourselves on being the industry leader in bringing institutional business practices to the cannabis industry," said MedMen CEO, Adam Bierman. “That thesis continues with the formation of the Fund which provides an unprecedented opportunity to monetize the fastest growing industry in the United States.”

Since 2009, MedMen Management has helped more than 100 businesses navigate the complexities of entering and succeeding in the burgeoning legal cannabis industry. The firm is widely considered the most institutional platform in the industry led by an executive management team with significant expertise in cultivation, extraction, production, and retail operations.

The Fund has partnered with prominent investment firm, Wicklow Capital, an active private company investor across many industries and stages.

"The cannabis business is very operationally intensive. There has yet to be a Fund platform that combines proprietary access to diversified investment opportunities coupled with execution capabilities in the same vehicle, until now," said MedMen Chief Strategy Officer, Chris Ganan.

For more information:
MedMen
Damian Solomon
Director of Cultivation
805-717-9323
www.medmen.com
Publication date:

Related Articles → See More